Ejung Moon

Group Leader @OxfordOncology @The_OIRO PhD Radiation Oncology Tumour Biology

[Ejung Moon @MoonEjung]

Dr Ejung Moon awarded MRC funding to target metastatic breast cancer’s “Achilles’ heel” https://t.co/ezRPIguUZH

[Ejung Moon @MoonEjung]

I’m excited to be part of the 5th FLASH Radiotherapy and Particle Therapy Conference (FRPT 2025) – #FRPT2025 – taking place 10-12 December.

10th of December, 13:30-14:30
ORAL PRESENTATION SESSION 01: HIGHEST SCORED ABSTRACTS I

Learn more and register: https://t.co/NH2EL3zTb3

[Ejung Moon @MoonEjung]

https://t.co/SHU2yCQRrE

It is finally official! I'm thrilled to share that our work exploring the role of iron in the FLASH effect is now published in Cell Death & Disease! 👏 😊

[Ejung Moon @MoonEjung]

Excited to share that our preprint on the role of iron in FLASH radiation is now live! Grateful for all the hard work from the team! We welcome feedback and look forward to the next steps.
https://t.co/Grh4f3LSii

[Ejung Moon @MoonEjung]

@DKirschMDPhD @MDAndersonNews I am shocked by this news. What a great loss. I will miss his sense of humour and the passion to science. My deepest sympathy to his family.

[Ejung Moon @MoonEjung]

First carbon therapy launched in Seoul, Korea.

[Ejung Moon @MoonEjung]

We can always find a good excuse to be out of the lab but still to be excited.
🍽️ 🐟 🍟 🍔 🍗
#MoonLab #Oxford #OxfordCancer

[Ejung Moon @MoonEjung]

Our collaborative publication with Dep Radiation Oncology at Severance Hospital. @iSEVERANCE
Great team work with Prof Ik Jae Lee, Jiyoung, Gilyeong, and Nuria @nuriavl1993 👏🥳
https://t.co/IsG8ZBtoEm #mdpicancers via @Cancers_MDPI
@The_OIRO @OxfordOncology @AraviveInc

[Ejung Moon @MoonEjung]

Our collaborative work with KNU-DUKE-OXFORD is now published in BJC. 🥳👏
#ManassantinA #TargetingHIF #BJC
https://t.co/NqhdOdWLFD

[Ejung Moon @MoonEjung]

Our commentary about FLASH radiation and ferroptosis is now published in BJR. 🥳🥳🥳
BIR Publications https://t.co/dFZtBvenqY

[eLife Community @eLifeCommunity]

Over at @eLife, we’re eliminating accept/reject decisions and relinquishing the traditional journal role of gatekeeper.

This new model is our move towards a fairer system that helps researchers get recognition for what, not where they publish. Read more: https://t.co/XIzOyb7W1l

[Ejung Moon @MoonEjung]

Our co-authored paper is now published in Cancer & Metabolism, https://t.co/B30igJ1PxH. This study highlights the role of ACSL3 in lipid droplet biogenesis and ferroptosis specifically in clear cell renal cell carcinoma (ccRCC).
https://t.co/wCO7WPc7T0

[Ejung Moon @MoonEjung]

Great opportunity to study APOBEC and cycling hypoxia to benefit breast cancer patients!#BreastCancerNow

[Ejung Moon @MoonEjung]

@bertm_li Congratulations, Albert! 👏🏻🎉🎁

[Ejung Moon @MoonEjung]

Becoming a YouTuber is not an easy job.
https://t.co/KwxOgpxJ6M

[Ejung Moon @MoonEjung]

#Scientists #OxfordOncology!

[Tiffany Ma @tiffany_s_ma]

Who run the world? Girls! #InternationalDayForWomenInScience #WomenInScience #WomenInStem @The_OIRO @OxfordOncology @UniofOxford @OxfordMedSci @Hammond_Lab @olcina_lab @MoonEjung @steminist

[Ejung Moon @MoonEjung]

A great accomplishment! Congratulations to @eileen_parkes!

[Oxford Cancer @OxfordCancer]

Congratulations to @eileen_parkes who has been awarded the prestigious and competitive @wellcometrust Clinical Research Career Development Fellowship

Read about her work in the immunology and genetics of oesophageal #cancer @OxfordOncology 🧬
https://t.co/0qYAyVGvaR

[Ejung Moon @MoonEjung]

@OxfordCancer @eileen_parkes @wellcometrust @OxfordOncology Congratulations!

[Ejung Moon @MoonEjung]

A great work to show an example of using metabolomics for early diagnosis.